Iran Vaccine Prioritisation
Cross-source consensus on Iran Vaccine Prioritisation from 1 sources and 5 claims.
1 sources · 5 claims
Uses
Background
Other
Other
Other
Highlighted claims
- Iran applied the WHO NVI-PST to guide vaccine introduction decisions for 2025-2030. — Application of the WHO new vaccine introduction prioritisation and sequencing framework to guide evidence-based vaccine introduction decisions in Iran, 2025–2030
- The case study was the first published application of the NVI-PST in the WHO Eastern Mediterranean Region. — Application of the WHO new vaccine introduction prioritisation and sequencing framework to guide evidence-based vaccine introduction decisions in Iran, 2025–2030
- The exercise was led by Iran's National Immunization Technical Advisory Group with coordination from the Ministry's Expanded Programme on Immunization and technical WHO support. — Application of the WHO new vaccine introduction prioritisation and sequencing framework to guide evidence-based vaccine introduction decisions in Iran, 2025–2030
- The final policy output was a prioritised vaccine roadmap for 2025-2030. — Application of the WHO new vaccine introduction prioritisation and sequencing framework to guide evidence-based vaccine introduction decisions in Iran, 2025–2030
- Iran already had near-universal EPI coverage but still had adolescent and adult life-course vaccination gaps. — Application of the WHO new vaccine introduction prioritisation and sequencing framework to guide evidence-based vaccine introduction decisions in Iran, 2025–2030